Fluidigm Corporation (FLDM)

7.78
NASDAQ
Prev Close 7.78
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.31 / 11.05
Exchange NASDAQ
Shares Outstanding 29.12B
Market Cap 226.54M
Div & Yield N.A. (N.A)

Latest News

Fluidigm Reaches Analyst Target Price

Fluidigm Reaches Analyst Target Price

In recent trading, shares of Fluidigm Corp have crossed above the average analyst 12-month target price of $8.05, changing hands for $8.12/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

5 Stocks Under $10 Poised for Big Breakouts

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to play them.

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

President-elect Trump's vague healthcare policy has put the $3 trillion industry on edge.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies, including Hertz, are scooping up shares of their own stock lately.

Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels For Immuno-Oncology Research

Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels For Immuno-Oncology Research

A comprehensive and flexible approach to deeply profile T cell phenotypes and function in immune checkpoint response

Fluidigm And GenomOncology Partner To Provide Automated Oncology NGS Library Preparation With Molecular Interpretation And Reporting

Fluidigm And GenomOncology Partner To Provide Automated Oncology NGS Library Preparation With Molecular Interpretation And Reporting

Empowering clinical research laboratories to achieve new levels of productivity

Fluidigm Becomes Oversold (FLDM)

Fluidigm Becomes Oversold (FLDM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Fluidigm At $5, Earn 16.1% Annualized Using Options

Commit To Buy Fluidigm At $5, Earn 16.1% Annualized Using Options

Investors considering a purchase of Fluidigm Corp shares, but cautious about paying the going market price of $8.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $5 strike, which has a bid at the time of this writing of 30 cents.

Oversold Conditions For Fluidigm (FLDM)

Oversold Conditions For Fluidigm (FLDM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Fluidigm Introduces New High-Throughput Targeted NGS Library Preparation System

Fluidigm Introduces New High-Throughput Targeted NGS Library Preparation System

Automated Juno Targeted DNA Sequencing Library Preparation System provides greater scalability and cost efficiency for sequencing laboratories

Fluidigm Appoints New President And Chief Operating Officer

Fluidigm Appoints New President And Chief Operating Officer

Seasoned Life Science industry veteran joins Fluidigm to lead sustainable growth

Trade These 7 Stocks Under $10 for Huge Profits

Trade These 7 Stocks Under $10 for Huge Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Fluidigm Introduces Single-Cell TCR Sequencing On The C1 System At Immunology 2016™

Fluidigm Introduces Single-Cell TCR Sequencing On The C1 System At Immunology 2016™

Whole transcriptome analysis links T cell clonotype with phenotype

Clontech Laboratories, Inc. Releases The SMART-Seq V4 Ultra Low Input RNA Kit For The Fluidigm C1 System

Clontech Laboratories, Inc. Releases The SMART-Seq V4 Ultra Low Input RNA Kit For The Fluidigm C1 System

New kit for single-cell transcriptome analysis offers vast improvement over the sensitivity of current technologies